• Kyodo

  • SHARE

A Kyoto University foundation is preparing to provide induced pluripotent stem cells, or iPS cells, for medical use from next March, using cells that have the reduced risk of transplant rejection thanks to the gene-editing tool CRISPR, a foundation official said Sunday.

The CiRA Foundation, an offshoot of the university’s Center for iPS Cell Research and Application, plans to increase the types of iPS cells it has, with the view to increasing the stock of cells that match nearly all Japanese and 95% of the world’s population.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)